In anticipation of Signify Research’s soon-to-be-published fourth iteration of its 'Digital Pathology – World – 2024' market report, our expert author Imogen Fitt reviews her January 2024 market predictions in a series of videos.

In this edition, she highlights a surge in FDA approvals for end-to-end solutions, emphasising the necessity of this for success in the US clinical market. While growth in the States is robust widespread adoption will also hinge on establishing a clear ROI for digitisation, likely through reimbursement.

So far this year there have been 7 FDA approvals for Digital pathology including:
1 - Proscia-Hamamatsu
2 - Hologic
3 - Indica Labs-Hamamatsu
4 - Scopio Labs
5 - Roche
6 - Philips
7 - Leica-Sectra

To discuss what this means for your business connect with Imogen (imogen.fitt@orsignifyresearch.net).

#digitalPathology #FDAapproval #marketintelligence #medicaltech

свернуть